Get alerts for new trials in your area by subscribing now
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
for
Advanced Solid Tumors, Ewing Sarcoma,
Location: Boston MA, New York NY, Houston TX, Duarte CA,
Sponsor: SEED Therapeutics, Inc.
Sex: All
Age: 16+
Code: NCT07197554
Phase1, Recruiting
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
for
Sarcoma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT07089992
Phase2, Recruiting
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
for
Cutaneous Squamous Cell Carcinoma,
Location: Uniondale NY, New York NY, Middletown NJ, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT05859074
Phase1, Recruiting
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
for
Recurrent Solid Tumor, Recurrent Ewing Sarcoma,
Location: Montreal, Washington D.C. DC, Toronto, Atlanta GA,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 1 - 30
Code: NCT04901702
Phase1, Phase2, Recruiting
Pediatric Radiation Therapy Registry
for
Sarcoma, Pediatric Brain Tumors
Location: Baltimore MD, Washington D.C. DC
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 0 - 26
Code: NCT07129317
Recruiting
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
for
Soft Tissue Sarcoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07049848
Phase2, Recruiting
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
for
Uterine Cancer, Rectal Cancer, Colon Cancer, Breast Cancer,
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: Female
Age: 18 - 50
Code: NCT06904365
Recruiting
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
for
MPNST, NF1, Sarcoma
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT05253131
Phase2, Recruiting
Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas